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Isolation and virulence factors of vero cyto toxin- 
producing Escherichia coli in human stool samples 
Denis Pikrard I ,  Daniel Stevens l ,  Leo Moriau ', Hermy Lior2 and Sabine Lauwers 
'Department of Microbiology, Akademisch Ziekenhuis Vrije Universiteit Brussel, Brussels, Belgium; 
'Laboratory Centre for Disease Control, Ottawa, Canada 
Objective: To evaluate the isolation rate of 0157 and non-0157 verocytotoxin-producing Escherichia col i  (VTEC) 
strains, t o  study the occurrence of additional virulence factors and to correlate these with clinical symptoms. 
Methods: Over more than 5 years, 17 296 unduplicated fecal samples submitted for routine culture were screened for 
VTEC by a single PCR detecting VTI, VT2 and its variants. Verocytotoxin B subunit genotypes of the isolates obtained 
by testing individual colonies in  positive samples were determined by a polymerase chain reaction-restriction fragment 
length polymorphism (PCR-RFLP) technique, the eaeA gene and the 60-MDa virulence plasmid by PCR, and the 
hemolytic phenotype by using CaClz-washed blood agar. 
Results: Verocytotoxin genes were found in  1.02% of the samples. Non-0157 VTEC strains were isolated in  0.66% and 
0157 in  0.17%. Overall, VTEC was less frequently isolated than Campylobacterand Salmonella but more frequently than 
Yersinia and Shigella. All cases except two siblings were epidemiologically unrelated. Cases of hemolytic uremic 
syndrome (HUS) were only observed in association with serogroup 0157, which seems to  be more pathogenic than the 
non-0157 strains. Among non-0157 VTEC strains, eaeA-positive strains are more frequently associated with clinical 
symptoms than are eaeA-negative strains. Other virulence factors correlate less closely with the presence of symptoms. 
Conclusions: VTEC is the third bacterial intestinal pathogen in  our study population. All stool samples from patients 
with diarrhea should be screened for the most frequent serogroup, 0157, or, if this is not possible, at least those from 
patients with bloody diarrhea. Non-0157 VTEC strains, especially if they are eaeA positive, are also associated with 
diarrhea, more often non-bloody. PCR or the new commercially available immunoassays could be used in selected cases, 
e.g. in patients suffering from HUS and in  cases of outbreaks. 
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INTRODUCTION 
Verocytotoxin-producing Escherichia coli (VTEC) causes 
watery or bloody diarrhea, sometimes complicated by 
hemorrhagic colitis or hemolytic uremic syndrome 
(HUS). Also referred to as Shiga toxins (Stx) because 
of their close relationship to Shiga toxin produced by 
Shigella dysenteviae type 1 ,  the verocytotoxins (VTs) 
associated with human disease include VT1, VT2 and 
Corresponding author and reprint requests: 
Denis Pierard, Department of Microbiology, Akademisch 
Ziekenhuis Vrije Universiteit Brussel, Laarbeeklaan, 
101, 8-1090 Brussels, Belgium 
Tel: +32 2 477 50 02 
E-mail: labomicro@az.vub.ac.be 
Fax: +32 2 477 50 15 
Accepted 19 May 1997 
53 1 
several variants of VT2 [I ,2]. In addition to VTEC of 
serotypes 0157:H7, 0 1  1l:H- and 0 2 6 : H l l  (the so- 
called enterohemorrhagic Escherichia coli (EHEC) 13 ], 
which manifest common clinical, epidemiologic and 
pathogenic features), more than 100 other serotypes of 
E. coli have been reported to produce these toxins [4J. 
Although some non-0157 VTEC strains also possess 
one or more other virulence factors [5], it is still not 
clear whether or not they are all pathogenic [6]. These 
additional virulence factors, first described in 0157:H7, 
are enterohemolysin production [7], the presence of a 
large-sized EHEC plasmid [XI and the property of 
producing attachmerit-effacement lesions encoded by 
the eaeA  gene [91. VTEC strains of serotype 0157:H7 
are easily detectable in most clinical laboratories, 
because they do not ferment sorbitol, in contrast to the 
great majority of other E. coli strains, and can be 
identified on a selective medium, such as sorbitol- 
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MacConkey agar; sorbitol-negative colonies can be 
agglutinated with anti-0157 antiserum or a latex kit 
[lo]. Other serotypes of VTEC, as well as the sorbitol- 
fermenting 0157:H- VTEC reported in Germany [ l l ]  
however, are much more difficult to detect. They 
are currently only recognizable by tests not currently 
used in diagnostic laboratories, such as VT production 
tests (cytotoxicity or ELISA) and molecular tests (DNA 
hybridisation or polymerase chain reaction, PCR)) 
[lo]. In a previous study [12] we found an isolation rate 
for 0157  VTEC strains of 0.2% in the stools routinely 
submitted to our laboratory and we detected a few 
non-0157 strains by performing cytotoxicity tests on a 
limited number of samples. In this study we present the 
results of a large-scale screening using a PCR-based 
protocol. In order to better evaluate the pathogenic 
significance of the non-0157 VTEC strains, additional 
virulence factors were studied and correlated with 
clinical symptoms. 
MATERIALS AND METHODS 
Samples 
Over more than five years, from October 1990 to 
December 1995, 17 296 unduplicated consecutive 
fecal samples submitted for routine culture to the 
laboratory of the Akademisch Ziekenhuis of the Vrije 
Universiteit, Brussels (AZ-VUB) were screened for 
VTEC by PCR. 
PCR screening 
Strains harboring verocytotoxin genes were searched for 
as described previously [13]. Briefly, during the first 
year of the study, 1 mL of MacConkey broth inoculated 
with a few drops of fecal suspension and incubated 
overnight was centrifuged for 1 min at high speed, and 
the pellet was resuspended, recentrifuged and finally 
suspended in nutrient broth. From the second year of 
the study on, a colony sweep (a loopful of confluent 
bacterial growth) taken from a primary MacConkey 
agar plate was directly suspended in nutrient broth. 
These suspensions were used as such in a P C R  reaction 
using a consensus primer pair amplifying VT1, VT2 
and its variants [14] (Table 1). After an initial denatura- 
tion of 5 min at 94OC, 30 cycles of amplification (90 s 
at 94"C, 60 s at 43°C and 60 s at 72OC) were per- 
formed. The amplified DNA was visualized by electro- 
phoresis through a 2% agarose gel and ethidium 
bromide staining. A strain of E. coli 0157:H7 isolated 
in the AZ-VUB (strain EH1) was used in each run as 
positive control, and E. coli ATCC 25922 as negative 
control. A sample was considered positive only if 
an amplified DNA band of the same molecular weight 
as the control was observed in at least two repeats of 
the P C R  reaction starting from the same overnight 
MacConkey broth or agar plate. 
For each PCR-positive sample, 10 colonies obtained 
on the MacConkey agar plate (the primary isolation 
plate or a subculture of the MacConkey broth) were 
analyzed separately using the same P C R  protocol in 
order to obtain the VTEC strain for further charac- 
terization. If no single colony was found positive, at  
least 10 more colonies were analyzed. If still none of 
the tested coliform colonies was positive in the P C R  
reaction, the sample was reported as P C R  positive 
without VTEC isolation. 
Table 1 Primers used in this study 
Expected 
product size 
Amplified genes Primer Sequence (base pairs) Reference 
Consensus primers amplifying all VT genes 
Specific amplification of VT1 
Specific amplification of VT2 and human 
variants VT2 vh-a and VT2 vh-b 
Specific amplification of VT2e the 
porcine VT2 variant 
Amplification of VT2 and its human 
variants, to be used for KFLP 
Specific amplification of the human VT2 
variants VT2 vh-a and VT2 vh-b 
MKI 
MK2 
VT1-a 
VT1-b 
VT2-a 
VT2-b 
VT2e-a 
VT2e-b 
VT2-c 
VT2-d 
VT2v-1 
VT2v-2 
5'-TTT ACG ATA GAC T T C  TCG AC-3' 
5'-CAC ATA TAA ATT ATT TCG CTC-3' 
5'-GAA GAG T C C  GTG GGA TTA CG-3' 
5'-AGC GAT GCA GCT ATT AAT AA-3' 
5'-TTA ACC ACA C C C  ACG GCA GT-3' 
S'-GCT CTG GAT GCA T C T  CTG GT-3' 
5'-CCT TAA CTA AAA GGA ATA TA-3' 
5'-CTG GTG GTG TAT GAT TAA TA-3' 
5'-AAG AAG ATG T T T  ATG GCG GT-3' 
5'-CAC GAA TCA GGT TAT GCC TC-3' 
5'-CAT TCA CAG TAA AAG TGG CC-3' 
5'-GGG TGC C T C  CCG GTG AGT TC-3' 
224 (VT1) 
227 (VT2) 
130 Pollard et al [16] 
346 Pollard et al [16] 
230 Johnson et a1 [17] 
285 Tyler et al [la] 
3x5 Tyler et al [18] 
Karch and Meyer [14] 
Detection of the eaeA gene AE 9 5'-ACG TTG CAG CAT GGG TAA CTC-3' 815 Gannon et al [19] 
Detection of sequences of the 60-MDa MFSlF 5'-ACG ATG TGG T T T  ATT CTG GA-3' 166 Fratamico et al 1201 
EHEC virulence ulasmid 
AE 10 5'-GAT CGG CAA CAG T T T  CAC CTG-3' 
5'-CTT CAC GTC ACC ATA CAT AT-3' MFSIR 
RFLP = Restriction ffagment length polymorphism. 
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Characterization of VTEC isolates 
Further characterization was performed on a subculture 
of one single PCR-positive colony. The isolates were 
identified as described before [12] by using classical 
biochemical tests. They were agglutinated with 0157  
antiserum and tested on the H7 antiserum-sorbitol 
fermentation medium [15]. The latter is a semi-solid 
medium including anti-H7 antiserum that immobilizes 
strains with H7 flagellar antigen. Sorbitol is included 
for confirmation of the absence of fermentation of 
this sugar. Serotyping of non-agglutinating strains 
and phage typing of 0 1 5 7  strains were performed 
at the Laboratory Centre for Disease Control, except 
for a few isolates from 1995 which were serotyped 
by E Scheutz, Statens Seruminstitut, Copenhagen, 
Denmark. 
Confirmation of VT production and B subunit genotyping 
Production of VT was confirmed by cytotoxicity tests 
on Vero cells [12]. The genotype of the B subunit was 
determined by separate P C R  primers for VTl ,  VT2 
[16] and VT2e [17] (Table 1); if a VT2 gene was 
detected, it was subtyped by using the polymerase chain 
reaction-restriction fragment length polymorphism 
(PCR-RFLP) scheme described by Tyler et a1 [18], 
which distinguishes between VT2, VT2 vh-a and VT2 
vh-b B subunit genotypes. 
Detection of Escherichia coli hemolysins 
E. coli hemolysin phenotypes, enterohemolysin (E-Hly) 
produced by EHEC [7] and a-hemolysin (a-Hly) 
produced by various E. coli isolates, were detected and 
characterized as described previously [5]. Briefly, the 
presence of hemolysis after overnight incubation on 
CaC11-washed blood agar and the absence of hemolysis 
on unwashed blood agar was considered as character- 
istic for the E-Hly phenotype. The presence of hemo- 
lysis on both plates was considered as characteristic of 
the a-Hly phenotype. 
Detection of the eaeA gene 
The eaeA gene was detected as described previously [5] 
in VTEC isolates by using primers described by 
Gannon et a l  1191 (Table 1). Briefly, a suspension made 
in nutrient broth was directly used in the P C R  mix. 
After an initial denaturation at 94OC for 5 min, 35 
cycles of 1 min at 94"C, 1 min at 55OC and 2 min at 
72OC were performed. A strain of E. coli 0357:H7 
isolated in the AZ-VUB (strain EH1) was used in each 
run as positive control and E. coli ATCC 25922 as 
negative control. 
Detection of sequences of the 60-MDa virulence plasmid 
The MFS primers (MSFlF and MFSlR, see Table 1) 
homologous to a portion of the 60-MUa virulence 
plasmid harbored by 0157:H7 E. coli were used as 
described by Frataniico et a1 [20]: after an initial 
denaturation of a bacterial suspension at 94OC for 
5 nlin, 35 cycles of 30 s at 94"C, 30 s at 55OC and 90 s 
at 72OC were performed. A strain of E. coli 0157:H7 
isolated in the AZ-VUB (strain EH1) was used in each 
run as positive control and E. coli ATCC 25922 as 
negative control. 
Clinical data and statistical tests 
Clinical data were collected by retrospective analysis 
of medical records. Hemorrhagic colitis was defined as 
a clinical syndrome consisting of important abdominal 
cramps accompanied by grossly bloody diarrhea. 
HUS was defined by the triad of hemolytic anemia 
with presence of fragmentocytes in peripheral blood 
thrombocytopenia and renal insufficiency; patients 
fitting this definition but lacking the renal insufficiency 
were considered to have an incomplete HUS. Other 
cases were classified as cases of bloody or non-bloody 
diarrhea, cases of abdominal pain without diarrhea, 
or cases where no relevant gastrointestinal symptoms 
were present. Statistical analysis was performed by using 
Yates corrected chi-squared tests or, if an expected 
value was less than 5, the one-tailed Fisher exact test. 
VT genes were detected in 177 out of 17 296 (1.02%) 
stool specimens analyzed during the study period. In 
143 of the 177 VT-positive cases (81%), a VTEC isolate 
could be recovered. All isolates were positive in the 
Vero cell cytotoxicity test. In the study population, 
Salmonella spp. were isolated in 583 patients (3.4%), 
Campylobacter jejuni/coli in 548 patients (3.2%), Yersinia 
spp. in 91 patients (0.53%) and Shkella spp. in 44 
Table 2 Number of VTEC isolates of the main serogroups 
by year 
~~ ~ 
1990 
Serogroup (3 months) 1991 1992 1993 1994 1995 Total 
0 1 5 7  
0 2 6  
0 9 1  
0 1 0 3  
0 1 1 1  
0 1 2 8  
0 1 4 5  
Other serotypes 
No isolate 
All 
1 6 9 5 4 4 29 
0 2 2 3 4 1 1 2  
1 3 3 3 1 0 1 1  
1 2 1 1  2 5 12 
1 2 0 1 0 2 6  
1 1 1 0 0 1 4  
0 0 1 1 3 0 5  
4 18 6 10 10 16 64 
1 10 4 2 12 7 36 
10 44 27 26 36 36 179 
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Table 3 Serotypes, virulence factors and VT genotypes of the isolated VTEC strains 
Virulence factors (number positive) 
No. of Hemolysin Virulence 
Serotype isolates eaeA phenotype plasmid VT genotypes 
0157:H7 
0 1  57:H- 
Subtotal 
0157  
01:H20 
02:H27 
04:H40 
06:H- 
07:H8 
08:H- 
015:H27 
018:H12 
020:H7 
022:Hl  
026:H- 
026:Hl l  
065:H16 
076:H19 
077:H4 
077:H18 
091:H- 
091:HlO 
091:H14 
091:H21 
091:H? 
0101:H9 
0103:H2 
0103:H? 
0 104:H7 
0 l l l : H -  
0 l l l : H S  
01 13:H4 
0 1 13:H2 1 
0115:H18 
0117:H7 
0 1  18:H12 
0 1  18:H16 
0128:H2 
0 145:H- 
O145:H16 
0 145:H? 
0146:H28 
0 1 50: H 1 0 
0 169:H- 
0X3:H2 
OX3:H21 
22 
7 
29 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
2 
10 
1 
1 
1 
1 
4 
2 
2 
1 
2 
1 
11 
1 
1 
5 
1 
2 
1 
2 
1 
1 
1 
4 
2 
2 
1 
2 
1 
1 
1 
1 
22 
7 
29 (100%) 
0 
0 
1 
1 
0 
0 
0 
0 
0 
1 
2 
9 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
11 
1 
0 
5 
1 
0 
0 
0 
0 
0 
1 
0 
2 
2 
1 
0 
0 
1 
0 
0 
E-Hly (22) 
E-Hly (7) 
E-Hly: 29 
(100%) 
E-Hly (1) 
No Hly (1) 
E-Hly (1) 
a-Hly (1) 
No Hly (1) 
No Hly (1) 
No Hly (1) 
No Hly (1) 
No Hly (1) 
a-Hly (1) 
E-Hly (1) 
No Hly (1) 
E-Hly (7) 
No Hly (3) 
E-Hly (1) 
No Hly (1) 
E-Hly (1) 
E-Hly (1) 
No Hly (4) 
No Hly (2) 
E-Hly (2) 
E-Hly (1) 
E-Hly (2) 
No Hly (1) 
E-Hly (1 1) 
E-Hly (1) 
No Hly (1) 
E-Hly (5) 
E-Hly (1) 
No Hly (2) 
No Hly (1) 
E-Hly (2) 
E-Hly (1) 
No Hly (1) 
E-Hly (1) 
E-Hly (4) 
E-Hly (2) 
E-Hly (2) 
E-Hly (1) 
E-Hly (2) 
E-Hly (1) 
E-Hly (1) 
E-Hly (1) 
No Hly (1) 
22 
7 
29 (100%) 
1 
0 
1 
1 
0 
0 
0 
0 
0 
1 
2 
8 
1 
0 
1 
1 
0 
0 
2 
1 
2 
0 
10 
1 
0 
5 
1 
0 
1 
2 
0 
0 
1 
3 
2 
2 
1 
0 
0 
1 
0 
0 
VTl+VT2 vh-a (3) 
VT2 vh-a (9) 
VT2+VT2 vh-a (10) 
VT1 +VT2 vh-a (6) 
VT2 vh-a (1) 
VT1 (1) 
VT2 (1) 
VT1 (1) 
VT1 (1) 
VT1 +VT2 vh-b (1) 
VT2e (1) 
VT1 +VT2 V-NT (1) 
VT2 V-NT (1) 
VT2 vh-a (1) 
VT1 (1) 
VT1 (1) 
VTI (9) 
VT2 vh-b (1) 
VTl+VT2+VT2 vh-b (1) 
VT2 vh-a (1) 
VT1 (1) 
VT2 (1) 
VTl+VT2 V-NT (4) 
VT2+VT2 vh-b (2) 
VT1 (1) 
VTl+VT2 (1) 
VT2 (1) 
VT1 (1) 
VT1 f V T 2  vh-b (1) 
VT2e (1) 
VT1 (11) 
VT1 (1) 
VT1 (1) 
VT1 (5) 
VT1 (1) 
VT2 V-NI (2) 
VT2 vh-b 
VT2 vh-b (1) 
VT2+VT2 vh-b (1) 
VT1 (1) 
VT2 V-NT (1) 
VT1 (1) 
VTl+VT2+ VT2 vh-b (4) 
VT1 (1) 
VT1 (2) 
VT1 (1) 
VT2 V-NT (1) 
VTl+VT2 V-NT (1) 
VT2 V-NT (1) 
VTI (1) 
VT2 (1) 
VT2 vh-a (1) 
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Table 3 continued 
Virulence factors (number positive) 
No of Hemolysin Virulence 
Serotypc isolates eaeA phenotype plasmid VT genotypes 
0 rough4 14 6 E-Hly (10) 1 0 VTI (6) 
No Hly (4) VT2 V-NT (1) 
VT2 v-NI (2) 
VT1 f V T 2  V-NT (5) 
VT typing not available ( I )  
20 
Suhtural n o n - 0 1 5 7  114 
3 E-Hly (6) 
N o  Hly (14) 
5 
48 (42%) E-Hly: 69 (61%) 67 (59%) 
a-Hly: 2 (2%) 
hi, Hly: 43 (38%) 
VT1 (6) 
VT2 (I)  
VT2 vh-a (1) 
VT2 vh-b (1) 
VT2 V-NT (4) 
VT2 V-NI (1) 
V T 2 f V T 2  vh-a (1)  
VTI f V T 2  V-NT (3) 
VT typing not available (2) 
E-Hly=enterohenmolysin phenotype; a-Hly=a-hemolysiri phenotype; No Hly=absenre of hemolysis on blood agar; O?=not  typeable 0 
antigen; H?-not typeable H antigen; H-=not motile (no flagellar antigen); VT2 v-NT=not typeable VT2 variant gene (no amplification 
with primers VT2-c and VTz-d); VT2 v-NI=non-interpretable RFLP pattern of VT, variant gene. 
'In combination with H2 (n=2), H12 (n=1), H25 (n=2), H38 (n=l), H- (n=S),  H? ( n = 3 ) .  
"In combination with H4 (w=l), H8 ( n = l ) ,  H10 ( t i = l ) ,  H12 (n=3),  HI4 (n=l ) ,  H16 (r l=3) ,  H I 9  (n=2) ,  H21 (n=2), H25 (t1=1), 
H-  (t1=1), H? (w=4). 
patients (0.25%). VTEC strains were isolated through- 
out the year, with only a moderate seasonal variation, 
60% of the cases being detected from June to October. 
Table 2 shows the number of isolates of the main 0 
serogroups by year: no peaks in isolation rate of any of 
these serogroups were observed. 
Twenty-nine of the 143 VTEC isolates (20.3%) 
belonged to serogroup 0157.  None of these strains 
fermented sorbitol after overnight incubation and all 
were p-glucuronidase negative. Seven strains produced 
urease and eight others were non-motile. As shown in 
Table 3, all possessed a VT2 gene, in combination with 
VT1 in nine cases (31%). All were positive for the three 
virulence factors searched for. Seven different phage 
types were identified: type 8 (n=12; eight non-motile 
strains), type 50 (rz=6; all urease positive), type 4 (n=3),  
type 2 (n=3; one urease-positive strain), type 14 (n=2),  
type 39 (n=2) and type 73 ( n = l ) .  The last strain was 
not typeable, as it reacted with phages according to a 
pattern that does not conform to the standard types. 
The 11 4 non-0157 strains all fermented sorbitol 
within 24 h, except for three strains: one 0 rough:H25, 
one 0150:H10 and one 0117:H7 (the latter did not 
ferment lactose either). All presented a positive p- 
glucuronidase test. Different strains of one serotype 
possessed generally the same virulence factors and VT 
genotypes or a limited number of combinations of 
these parameters. VT genotyping could not be per- 
formed on three strains which probably lost their VT 
genes during storage; they belonged to serotypes 0 
rough:H38, O?:M10 and 0?:H12. Fifty-six (51'%,) of 
the remaining 111 strains harbored the VT1 gene, 32 
(29%) a VT2 gene (including two VT2e, the porcine 
variant gene) and 23 (21%)) both VT1 and VT2 genes. 
The two VT2e-harboring strains were isolated from a 
62-year-old man (strain of serotype 0 1  01 :H9) 12 11 and 
an 80-year-old woman (strain of serotype 08:H-),  
both with non-bloody diarrhea. Forty-eight (42%) of 
the non-0157 strains were positive for the e n d  
gene. Harboring a VT1 gene alone was associated with 
possessing the eaeA gene: 45 of 56 (80.4%) VTI-  
positive strains but only three of 55 (5.5%) VT2 
or VT1 +VT2-positive strains were eueA positive 
(p<0.0000001). Most enehpositive strains were also 
positive for the two other virulence factors studied: 
only five of them were not hemolytic (two strains), 
negative for MFS primers (one strain), or both (two 
strains). In addition, 22 caeA-negative strains were 
hemolytic and possessed the virulence plasmid. Five 
more strains were hemolytic only. The clinical data of 
all VTEC-positive patients are shown in Table 4. To 
our knowledge, all cases were unrelated, with the 
ln 
w 
(I) 
Table 4 Clinical data for all VTEC-positive patients 
Number of patients 
Sex ratio (M/F) 
Age: median 
Age range 
Age: number 5 5  years 
Age: number 265  years 
Number with other 
intestinal pathogen(s) 
Clinical data (number auailablel” 
HUS 
Hemorrhagic colitis 
Bloody diarrhea 
Non-bloody diarrhea 
(A) (B) (C) (D) 
Patients Patients with eaeA- Patients with eaeA- Patients with positive 
with 0157 postive non-0157 negative non-0157 PCR without VTEC 
AU patients VTEC strain VTEC strain VTEC strain isolation A versus B+C B versus C 
177 
78/99 
3 years 2 months 
6 days to 91 years 
107 (60%) 
27 (15%) 
15 (8%) 
139 
4 (3%) 
4 (3%) 
12 (9%) 
66 (47%) 
29 
12/17 
2 years 5 months 
6 months to 91 years 
23 (79%) 
2 (7%) 
1(4%) 
25 
3 (12%) 
5 (20%) 
11 (44%) 
2 (8%) 
Sum of all patients with diarrhea 86 (62%) 21 (84%) 
Abdominal pain only 19 (14%) 
No gastrointestinal symptoms 34‘ (25%) 
1 (4%) 
3 (12%) 
48 
21/27 
1 year 5 months 
1 month to 87 years 
42 (88%) 
4 (8%) 
7 (15%) 
35 
0 
1(3%) 
3 (9%) 
24 (69%) 
28 (80%) 
66 
25/41 
14 years 11 months 
6 days to 91 years 
20 (30%) 
17 (26%) 
4 (6%) 
56 
0 
1(2%) 
1(2%) 
20 (36%) 
22 (39%) 
34 
20/14 
2 years 7 months 
5 months to 90 years 
21 (62%) 
4 (12%) 
3 (9%) 
23 
l b  (4%) 
0 
3 (13%) 
11 (48%) 
15 (65%) 
0 -. 
J -. 
0 
W p=0.03 p<0.0000001 - 
z -. p=0.03 
0 
0 
fn 
-c 
p=0.008 W 3 
Q 
3 
m 
0 
0 
- 
p=0.03 
-I. 
p=0.02 p=0.0002 3 
p=0.0012 
e _. 
3 (9%) 
4‘ (11%) 
13 (23%) 
21 (38%) 
2 (9%) c 
6 (26%) p=0.008 
“Includes only patients without other intestinal pathogens. 
hIncomplete HUS: microangiopathic anemia without renal insuficiency 
“Includes one patient with idiopathic thrombocytopenic purpura (see text). 
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exception of two siblings. Only four cases of HUS were 
observed, three complete HUS cases associated with 
the isolation of an 0 1 5 7  strain and one incomplete 
HUS with positive P C R  without VTEC isolation. 
Four cases of hemorrhagic colitis were associated with 
an 0157:H7 strain (n=2), an eaeA-positive 022 :Hl  
strain (n= l )  and an eaerl-negative 077:H4 strain 
( n = l ) .  The isolation of an eaerl-positive 0145:H- 
strain in a child without gastrointestinal symptoms but 
presenting idiopathic thrombocytopenic purpura (ITP) 
was probably fortuitous, and this case has been classified 
in the group of patients without gastrointestinal symp- 
toms. In 15 patients (8%), another intestinal pathogen 
was also isolated from the same stool sample; for 
the computing of clinical data, these patients were 
excluded. When the clinical data from patients with 
positive P C R  but without VTEC isolation (D) were 
compared to those of all patients with VTEC isolates 
(A+B+C), no statistical difference was found for any of 
the parameters shown in Table 4. However, in the 
group of patients with VTEC isolation, patients 
infected with 0 157 strains (A) presented significantly 
more often with diarrhea, bloody diarrhea or HUS 
than those infected with non-0157 strains (B+C). The 
proportion of patients 5 5  years old was significantly 
lower in the latter subgroups (54% versus 79%). 
It  appears that in patients infected with a non- 
0157  VTEC strain, the correlation of virulence factors 
with clinically significant infection is most pronounced 
for the attachment-effacement property: 28 of the 35 
patients (80%) infected with an eaeA-positive strain but 
only 22 of the 56 patients (39%) infected with an eaeil- 
negative strain presented diarrhea, with or without 
complications (p=0.0002). Age distribution in eaeA- 
positive non-0157 patients, as shown by the per- 
centage of patients 5 5  years old (88% in this group), is 
similar to that in 0 1  57 patients (79%) but significantly 
different from that in eaekl-negative non-0157 patients 
(30%)) ( p <  0.0000001). The other virulence factors 
were also significantly more frequent in diarrheic 
patients, with p=0.02 for hemolytic activity, either 
enterohemolysis or a-hemolysis, and p=0.04 for the 
virulence plasmid. Moreover, patients with a VT1- 
producing strain presented more frequently with 
symptoms than did patients with VT2- or VT1 +VT2- 
producing strains (p=0.01). 
DISCUSSION 
In contrast with many other studies, we focused not 
only on VTEC of serotype 0157:H7 and its non- 
motile variant 0257:H- but on all VTEC serotypes. 
Evidence for the presence of VTEC strains was found 
in 1.02% of the stool specimens submitted to our 
laboratory for routine culture and a VTEC strain was 
isolated in 0.83%, meaning that these organisms com- 
prise the third most important bacterial intestinal 
pathogen, far below Salmonella and Campylobacter but 
above Yersinia and Sh&ella. 
As in other studies where the PCR was applied on 
clinical material and not on pure bacterial suspensions 
[22-251, in some of the PCK-positive samples (19%) 
we failed to isolate the VTEC strain. Paton et al, using 
a protocol similar to ours, could not isolate a VTEC in 
five of 21 PCR-positive samples (24%) from patients 
involved in an HUS outbreak due to E. coli 0 1  I1 :H- 
[25]. Mariani-Kurkdjian et al, were unable to culture 
VTEC in 19 of 51 PCR-positive stools (37'%) from 
patients with HUS [23]. The explanation for this 
phenomenon is probably to be found in the high 
sensitivity of the P C R  technique, which is still positive 
when a VTEC strain is mixed with VT-negative E. coli 
in a proportion as low as lo-" (personal observation) 
to lo-* [22]. Several factors argue against false-positive 
PCR reactions: first, all positive reactions were 
repeated, excluding contamination during the per- 
formance of the PCR; second, in a limited number of 
samples (nine of the 34) from which no VTEC strain 
was isolated, a P C R  with separate primers for VT1 and 
VT2 [16] was performed as well on the originally 
PCK-positive suspension and was always positive, for 
VT1 in six cases, VT2 in one case and both in two cases 
(data not shown). Finally, although the screening 
primers used in this study were consensus primers each 
containing one to two mismatches to the sequence of 
VT1 or VT2 that imposes the use of a low annealing 
temperature, the reaction seems to be very specific, 
since none of the isolated colonies yielding a positive 
reaction was negative when tested with the separate 
primers for VT1 or VT2 mentioned above. 
Although isolated from only 0.17% of the stool 
saniples, a percentage lower than the 0.25% of Shigdla, 
0 1 5 7  VTEC strains represented the predominant 
VTEC serogroup in our study. This isolation rate is 
very comparable to the 0.1-0.5% reported in other 
European studies [26,27], while Canadian and US 
studies have generally reported higher rates, ranging 
from 0.4% to 2.9% [28-301. The rather low rate in our 
study agrees with animal and meat data obtained in 
Belgium: 0 1 5 7  strains were not found among VTEC 
isolated from calves suffering from diarrhea [31] and in 
VTEC isolated from meat samples [32]. The patho- 
genicity of 0157  VTEC strains was objectified in our 
study by the presence of several additional virulence 
factors: all isolates possessed the eaeA gene, produced 
enterohemolysin and harbored the 60 MDa virulence 
plasmid. All harbored a VT2 vh-a gene, alone or in 
combination with VTl  or VT2 genes. As many as 88% 
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of the patients infected with an 0157  strain presented 
with diarrhea; 12% presented with HUS. 
Non-0157 strains were isolated from 0.66% of 
samples. In comparison, the isolation rates of non- 
0157  VTEC strains reported in the US [29,30], 
Canada [33], Switzerland [34] and Germany [26] has 
ranged from 0.07% to 2.35%. The 80 strains that could 
be 0 serogrouped (excluding rough and 0 non-type- 
able strains) belonged to 30 different 0 serogroups 
corresponding to at least 40 serotypes. Six serogroups, 
0 2 6 ,  0103, 0 9 1 ,  0111,  0 1 4 5  and 0128, comprised 
50 (63%) of these strains. These six serogroups have all 
been associated with HUS and hemorrhagic colitis 
occurring as sporadic cases or outbreaks [28,35-391. 
The non-0157 VTEC strains were less frequently 
found to be positive for the additional virulence factors. 
It appears that patients infected with a non-0157 
strain producing only VT1 presented more often with 
VTEC-associated symptoms. These strains, however, 
were very often eaeA positive (SO%, compared with 5% 
for VT2- or VT1 +VT2-producing strains). Moreover, 
all isolates of four of the six most frequently isolated 
end-positive serogroups, 0 2 6 ,  0103, 0111 and 0145, 
produced VT1 alone, except for one, 026:H11, which 
produced VT2 vh-b. Overall, the presence of addi- 
tional virulence factors seems to be correlated with 
certain non-0157 serotypes, some of which have been 
reported as the cause of epidemics. There is also a 
parallel between serotypes and VT genotypes. The 
presence of the eaeA gene provides the best correlation 
with clinical signs: the patients with an eaeA-positive 
strain presented VTEC-associated symptoms in 80% of 
cases (but no case of HUS was seen in this group) and 
were younger than patients with an eaeA-negative 
strain, who presented symptoms in only 39% of cases. 
Nevertheless, the latter group included a patient with 
hemorrhagic colitis, infected with a strain of serotype 
077:H4. Additional virulence factors such as the 
presence of the virulence plasmid and the entero- 
hemolysin phenotype are frequently present in eaeA- 
negative strains but are less closely correlated with 
clinical symptoms. 
Although the pathogenicity of non-0157 VTEC 
strains is clearly associated with possession of the eaeA 
gene, eaeA-negative strains can be fully pathogenic, as 
for instance 0113:H21 [40]. In these eaeti-negative 
strains, other virulence factors can be involved, as 
has been recently reported for O l l l : H 2  [43]. Con- 
sequently, all patients harboring a VT-producing 
organism, E. coli as well as others such as VT-producing 
Citvobactevfreundii or Enterobacter cloacae [42,43], may be 
at risk for developing HUS. VTs are indeed responsible 
for lesions of the endothelial cells in capillaries of the 
gut, kidney and brain, leading to thrombotic micro- 
angiopathy, clinically manifested in the most severe 
cases by the appearance of hemorrhagic colitis or HUS 
[44,45]. 
Until now the detection of non-0157 strains has 
not been possible for most clinical laboratories [lo]. At 
the present time, different P C R  protocols for the 
detection of VTEC have been published, making 
diagnosis of VTEC non-0157 infections possible, but 
these techniques are not yet widely used in clinical 
laboratories [14,16,22,23]. In addition, kits for VT 
detection by immunologic methods are now commer- 
cially available (Premier E. coli Toxin test, Meridian 
Diagnostics, Inc.; VTEC-RPLA, Oxoid Ltd.). By 
using these PCR or immunologic techniques, it will be 
possible to better define the role of non-0157 VTEC 
strains-and even of other VT-producing organisms- 
as etiologic agents of diarrhea, hemorrhagic colitis and 
HUS. 
Taking into account the respective isolation rates 
of 0157  and non-0157 VTEC strains, their involve- 
ment in the development of HUS and the high cost of 
detection techniques for non-0157 strains, it is justi- 
fiable to screen stool samples for 0157  VTEC strains 
in all patients with diarrhea, or if that is not possible, at 
least in all patients with bloody diarrhea. Non-0157 
VTEC strains should be searched for in cases of HUS, 
in their contacts presenting with diarrhea and during 
outbreaks of diarrhea. 
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